Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-15-081889

Chief Executive Officer bought 535 shares at $1.76 ($941)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-11-23 Purchase : show line 1 in the form +535 $1.76 $941 6,835 D
Open-market purchases · 535 sh · avg $1.76 · $941
Loading xslF345X03/doc4.xml…